How is patient care for multiple myeloma advancing?-Reference-Cited by-同舟云学术

How is patient care for multiple myeloma advancing?

Published:2017-05-19 Issue:6 Volume:10 Page:551-561
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Genadieva Stavric Sonja¹,Bonello Francesca²,Bringhen Sara²,Boccadoro Mario²,Larocca Alessandra²

Affiliation:

1. Medical Faculty, University Hematology Clinic, Skopje, Macedonia

2. Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2017.1326814

Reference77 articles.

1. Multiple Myeloma

2. Myeloma - SEER stat fact sheets [internet]. Available from: http://seer.cancer.gov/statfacts/html/mulmy.html.

3. Lonial S. Treatment of MM: upcoming novel therapies [Internet]. Cancer Treat Res. 2016;169:195–205. Available from http://www.ncbi.nlm.nih.gov/pubmed/27696264

4. Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma

5. Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical Pharmacokinetics, Tissue Distribution and in vitro Metabolism of FHND6091, a Novel Oral Proteasome Inhibitor;Drug Design, Development and Therapy;2022-09

2. Patient‐reported pain severity and health‐related quality of life in patients with multiple myeloma in real world clinical practice;Cancer Reports;2021-06-10

3. Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression;Blood;2021-03-01

4. Alignment of preferences in the treatment of multiple myeloma – a discrete choice experiment of patient, carer, physician, and nurse preferences;BMC Cancer;2020-06-11

5. Towards the integration of patient-reported outcomes into the global clinical management of multiple myeloma;Expert Review of Hematology;2019-08-28